Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case–control studies
详细信息 查看全文
- 作者：Mette T. Faber (1)
Susanne K. Kj?r (1) (2)
Christian Dehlendorff (3)
Jenny Chang-Claude (4)
Klaus K. Andersen (3)
Estrid H?gdall (1) (5)
Penelope M. Webb (6)
Susan J. Jordan (6)
Mary Anne Rossing (8) (9)
Jennifer A. Doherty (10) (8)
Galina Lurie (11)
Pamela J. Thompson (11)
Michael E. Carney (11)
Marc T. Goodman (11)
Roberta B. Ness (12)
Francesmary Modugno (13)
Robert P. Edwards (14)
Clareann H. Bunker (15)
Ellen L. Goode (16)
Brooke L. Fridley (17)
Robert A. Vierkant (17)
Melissa C. Larson (17)
Joellen Schildkraut (18) (19)
Daniel W. Cramer (20)
Kathryn L. Terry (21)
Allison F. Vitonis (20)
Elisa V. Bandera (21)
Sara H. Olson (22)
Melony King (23)
Urmila Chandran (21)
Lambertus A. Kiemeney (24) (25) (26)
Leon F. A. G. Massuger (27)
Anne M. van Altena (27)
Sita H. Vermeulen (24)
Louise Brinton (28)
Nicolas Wentzensen (28)
Jolanta Lissowska (29)
Hannah P. Yang (28)
Kirsten B. Moysich (30)
Kunle Odunsi (31)
Karin Kasza (30)
Oluwatosin Odunsi-Akanji (30)
Honglin Song (32)
Paul Pharaoh (32)
Mitul Shah (32)
Alice S. Whittemore (33)
Valerie McGuire (33)
Weiva Sieh (33)
Rebecca Sutphen (34)
Usha Menon (35)
Simon A. Gayther (36)
Susan J. Ramus (37)
Aleksandra Gentry-Maharaj (35)
Celeste Leigh Pearce (36)
Anna H. Wu (36)
Malcolm C. Pike (22) (36)
Harvey A. Risch (37)
Allan Jensen (1) - 关键词：Case–control studies ; Histological type ; Ovarian neoplasms ; Smoking
- 刊名：Cancer Causes and Control
- 出版年：2013
- 出版时间：May 2013
- 年：2013
- 卷：24
- 期：5
- 页码：989-1004
- 全文大小：472KB
- 参考文献：1. Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61(2):69-0 CrossRef
2. Karim-Kos HE, de Vries E, Soerjomataram I et al (2008) Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 44(10):1345-389 CrossRef
3. Jordan SJ, Whiteman DC, Purdie DM et al (2006) Does smoking increase risk of ovarian cancer? A systematic review. Gynecol Oncol 103(3):1122-129 CrossRef
4. Gates MA, Rosner BA, Hecht JL et al (2010) Risk factors for epithelial ovarian cancer by histologic subtype. Am J Epidemiol 171(1):45-3 wp314">CrossRef
5. Gram IT, Lukanova A, Brill I et al (2012) Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC cohort study. Int J Cancer 130(9):2204-210 CrossRef
6. Terry PD, Miller AB, Jones JG et al (2003) Cigarette smoking and the risk of invasive epithelial ovarian cancer in a prospective cohort study. Eur J Cancer 39(8):1157-164 CrossRef
7. Tworoger SS, Gertig DM, Gates MA et al (2008) Caffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer. Cancer 112(5):1169-177 CrossRef
8. Green A, Purdie D, Bain C et al (2001) Cigarette smoking and risk of epithelial ovarian cancer (Australia). Cancer Causes Control 12(8):713-19 CrossRef
9. Huusom LD, Frederiksen K, Hogdall EV et al (2006) Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study. Cancer Causes Control 17(6):821-29 CrossRef
10. Jordan SJ, Green AC, Whiteman DC et al (2007) Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum? Gynecol Oncol 107(2):223-30 CrossRef
11. Marchbanks PA, Wilson H, Bastos E et al (2000) Cigarette smoking and epithelial ovarian cancer by histologic type. Obstet Gynecol 95(2):255-60 CrossRef
12. Modugno F, Ness RB, Cottreau CM (2002) Cigarette smoking and the risk of mucinous and nonmucinous epithelial ovarian cancer. Epidemiology 13(4):467-71 CrossRef
13. Pan SY, Ugnat AM, Mao Y et al (2004) Association of cigarette smoking with the risk of ovarian cancer. Int J Cancer 111(1):124-30 CrossRef
14. Riman T, Dickman PW, Nilsson S et al (2001) Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study. Gynecol Oncol 83(3):575-85 CrossRef
15. Rossing MA, Cushing-Haugen KL, Wicklund KG et al (2008) Cigarette smoking and risk of epithelial ovarian cancer. Cancer Causes Control 19(4):413-20 CrossRef
16. Soegaard M, Jensen A, Hogdall E et al (2007) Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study. Cancer Epidemiol Biomarkers Prev 16(6):1160-166 CrossRef
17. Zhang Y, Coogan PF, Palmer JR et al (2004) Cigarette smoking and increased risk of mucinous epithelial ovarian cancer. Am J Epidemiol 159(2):133-39 wh015">CrossRef
18. Kurian AW, Balise RR, McGuire V et al (2005) Histologic types of epithelial ovarian cancer: have they different risk factors? Gynecol Oncol 96(2):520-30 CrossRef
19. Gram IT, Braaten T, Adami HO et al (2008) Cigarette smoking and risk of borderline and invasive epithelial ovarian cancer. Int J Cancer 122(3):647-52 CrossRef
20. Goodman MT, Tung KH (2003) Active and passive tobacco smoking and the risk of borderline and invasive ovarian cancer (United States). Cancer Causes Control 14(6):569-77 CrossRef
21. Kuper H, Titus-Ernstoff L, Harlow BL et al (2000) Population based study of coffee, alcohol and tobacco use and risk of ovarian cancer. Int J Cancer 88(2):313-18 CrossRef
22. Collaborative Group on Epidemiological Studies of Ovarian Cancer (2012) Ovarian cancer and smoking: individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studies. Lancet Oncol 13(9):946-56 CrossRef
23. Ramus SJ, Vierkant RA, Johnatty SE et al (2008) Consortium analysis of 7 candidate SNPs for ovarian cancer. Int J Cancer 123(2):380-88 CrossRef
24. Merritt MA, Green AC, Nagle CM et al (2008) Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer. Int J Cancer 122(1):170-76 CrossRef
25. Risch HA, Bale AE, Beck PA et al (2006) PGR +331 A/G and increased risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 15(9):1738-741 CrossRef
26. Rossing MA, Cushing-Haugen KL, Wicklund KG et al (2007) Menopausal hormone therapy and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 16(12):2548-556 CrossRef
27. Royar J, Becher H, Chang-Claude J (2001) Low-dose oral contraceptives: protective effect on ovarian cancer risk. Int J Cancer 95(6):370-74 CrossRef
28. Ness RB, Dodge RC, Edwards RP et al (2011) Contraception methods, beyond oral contraceptives and tubal ligation, and risk of ovarian cancer. Ann Epidemiol 21(3):188-96 CrossRef
29. Glud E, Kjaer SK, Thomsen BL et al (2004) Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer. Arch Intern Med 164(20):2253-259 CrossRef
30. Kelemen LE, Sellers TA, Schildkraut JM et al (2008) Genetic variation in the one-carbon transfer pathway and ovarian cancer risk. Cancer Res 68(7):2498-506 CrossRef
31. Schildkraut JM, Iversen ES, Wilson MA et al (2010) Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer. PLoS One 5(4):e10061 CrossRef
32. Terry KL, De Vivo I, Titus-Ernstoff L et al (2005) Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk. Cancer Res 65(13):5974-981 CrossRef
33. Bandera EV, King M, Chandran U et al (2011) Phytoestrogen consumption from foods and supplements and epithelial ovarian cancer risk: a population-based case control study. BMC Womens Health 11:40 CrossRef
34. Garcia-Closas M, Brinton LA, Lissowska J et al (2007) Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study. BMC Cancer 7:60 CrossRef
35. Song H, Ramus SJ, Quaye L et al (2006) Common variants in mismatch repair genes and risk of invasive ovarian cancer. Carcinogenesis 27(11):2235-242 CrossRef
36. McGuire V, Felberg A, Mills M et al (2004) Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations. Am J Epidemiol 160(7):613-18 wh284">CrossRef
37. Pal T, Permuth-Wey J, Betts JA et al (2005) BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 104(12):2807-816 CrossRef
38. Narod SA, Risch H, Moslehi R et al (1998) Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group. N Engl J Med 339(7):424-28 CrossRef
39. Balogun N, Gentry-Maharaj A, Wozniak EL et al (2011) Recruitment of newly diagnosed ovarian cancer patients proved challenging in a multicentre biobanking study. J Clin Epidemiol 64(5):525-30 CrossRef
40. Goodman MT, Lurie G, Thompson PJ et al (2008) Association of two common single-nucleotide polymorphisms in the CYP19A1 locus and ovarian cancer risk. Endocr Relat Cancer 15(4):1055-060 CrossRef
41. Goode EL, Chenevix-Trench G, Song H et al (2010) A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet 42(10):874-79 CrossRef
42. Pike MC, Pearce CL, Peters R et al (2004) Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study. Fertil Steril 82(1):186-95 CrossRef
43. Wu AH, Pearce CL, Tseng CC et al (2009) Markers of inflammation and risk of ovarian cancer in Los Angeles County. Int J Cancer 124:1409-415 CrossRef
44. Risch HA, Jain M, Marrett LD et al (1994) Dietary fat intake and risk of epithelial ovarian cancer. J Natl Cancer Inst 86(18):1409-415 CrossRef
45. Baker JA, Odunuga OO, Rodabaugh KJ et al (2006) Active and passive smoking and risk of ovarian cancer. Int J Gynecol Cancer 16(Suppl 1):211-18 CrossRef
46. Stukel TA, Demidenko E, Dykes J et al (2001) Two-stage methods for the analysis of pooled data. Stat Med 20(14):2115-130 CrossRef
47. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177-88 CrossRef
48. Leffondré K, Abrahamowitz M, Siemiatycki J et al (2002) Modeling smoking history: a comparison of different approaches. Am J Epidemiol 156:813-23 wf122">CrossRef
49. Massey F Jr (1951) The Kolmogorov-Smirnov test for goodness of fit. J Am Stat Assoc 46(253):68-8 CrossRef
50. Gilks CB, Ionescu DN, Kalloger SE et al (2008) Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma. Hum Pathol 39(8):1239-251 CrossRef
51. R: A Language and Environment for Statistical Computing (2011) R Foundation for Statistical Computing, Vienna, Austria
52. Kotsopoulos J, Baer HJ, Tworoger SS (2010) Anthropometric measures and risk of epithelial ovarian cancer: results from the nurses-health study. Obesity (Silver Spring) 18(8):1625-631 CrossRef
53. Eriksen M, Mackay J, Ross H (2012) The tobacco atlas. American Cancer Society, Atlanta
54. Riman T, Dickman PW, Nilsson S et al (2004) Some life-style factors and the risk of invasive epithelial ovarian cancer in Swedish women. Eur J Epidemiol 19(11):1011-019 CrossRef
55. Nagle CM, Olsen CM, Webb PM et al (2008) Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors. Eur J Cancer 44(16):2477-484 CrossRef
56. Chen KM, Zhang SM, Aliaga C et al (2012) Induction of ovarian cancer and DNA adducts by Dibenzo[a, l]pyrene in the mouse. Chem Res Toxicol 25(2):374-80 CrossRef
57. Zenzes MT, Puy LA, Bielecki R (1998) Immunodetection of benzo[a]pyrene adducts in ovarian cells of women exposed to cigarette smoke. Mol Hum Reprod 4(2):159-65 CrossRef
58. Risch HA, Marrett LD, Jain M et al (1996) Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study. Am J Epidemiol 144(4):363-72 CrossRef
59. Gilks CB, Prat J (2009) Ovarian carcinoma pathology and genetics: recent advances. Hum Pathol 40(9):1213-223 CrossRef
60. Plummer M, Herrero R, Franceschi S et al (2003) Smoking and cervical cancer: pooled analysis of the IARC multi-centric case–control study. Cancer Causes Control 14(9):805-14 CrossRef
61. Slattery ML, Potter JD, Friedman GD et al (1997) Tobacco use and colon cancer. Int J Cancer 70(3):259-64 CrossRef
62. Lindemann K, Vatten LJ, Ellstrom-Engh M et al (2008) Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study. Br J Cancer 98(9):1582-585 CrossRef
63. Kurman RJ, Shih I (2010) The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 34(3):433-43 CrossRef
64. Pandeya N, Williams GM, Green AC et al (2009) Do low control response rates always affect the findings? Assessments of smoking and obesity in two Australian case-control studies of cancer. Aust N Z Public Health 33:312-19 CrossRef
65. Greenland S, O’Rourke K (2008) Meta-analysis. In: Rothman KJ, Greenland S, Lash T (eds) Modern epidemiology, 3rd edn. Lippincott Williams and Wilkins, Philadelphia, pp 652-82 - 作者单位：Mette T. Faber (1)
Susanne K. Kj?r (1) (2)
Christian Dehlendorff (3)
Jenny Chang-Claude (4)
Klaus K. Andersen (3)
Estrid H?gdall (1) (5)
Penelope M. Webb (6)
Susan J. Jordan (6)
Mary Anne Rossing (8) (9)
Jennifer A. Doherty (10) (8)
Galina Lurie (11)
Pamela J. Thompson (11)
Michael E. Carney (11)
Marc T. Goodman (11)
Roberta B. Ness (12)
Francesmary Modugno (13)
Robert P. Edwards (14)
Clareann H. Bunker (15)
Ellen L. Goode (16)
Brooke L. Fridley (17)
Robert A. Vierkant (17)
Melissa C. Larson (17)
Joellen Schildkraut (18) (19)
Daniel W. Cramer (20)
Kathryn L. Terry (21)
Allison F. Vitonis (20)
Elisa V. Bandera (21)
Sara H. Olson (22)
Melony King (23)
Urmila Chandran (21)
Lambertus A. Kiemeney (24) (25) (26)
Leon F. A. G. Massuger (27)
Anne M. van Altena (27)
Sita H. Vermeulen (24)
Louise Brinton (28)
Nicolas Wentzensen (28)
Jolanta Lissowska (29)
Hannah P. Yang (28)
Kirsten B. Moysich (30)
Kunle Odunsi (31)
Karin Kasza (30)
Oluwatosin Odunsi-Akanji (30)
Honglin Song (32)
Paul Pharaoh (32)
Mitul Shah (32)
Alice S. Whittemore (33)
Valerie McGuire (33)
Weiva Sieh (33)
Rebecca Sutphen (34)
Usha Menon (35)
Simon A. Gayther (36)
Susan J. Ramus (37)
Aleksandra Gentry-Maharaj (35)
Celeste Leigh Pearce (36)
Anna H. Wu (36)
Malcolm C. Pike (22) (36)
Harvey A. Risch (37)
Allan Jensen (1)
1. Unit of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Strandboulevarden 49, 2100, Copenhagen, Denmark
2. Gynecologic Clinic, Copenhagen University Hospital, Copenhagen, Denmark
3. Unit of Statistics, Bioinformatics and Registry, Danish Cancer Society Research Center, Strandboulevarden 49, 2100, Copenhagen, Denmark
4. Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany
5. Molecular Unit, Department of Pathology, Herlev University Hospital, University of Copenhagen, Copenhagen, Denmark
6. Population Health Department, Queensland Institute of Medical Research, Brisbane, Australia
8. Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
9. Department of Epidemiology, University of Washington, Seattle, WA, USA
10. Department of Community and Family Medicine, Section of Biostatistics and Epidemiology, The Geisel School of Medicine at Dartmouth, Lebanon, NH, USA
11. Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA
12. School of Public Health, University of Texas, Houston, TX, USA
13. Division of Gyn/Onc, Department of Ob/Gyn/RS, School of Medicine and Department of Epidemiology, Graduate School of Public Health, Ovarian Cancer Center of Excellence, Women’s Cancer Program, Magee-Women’s Research Institute, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA, USA
14. Division of Gyn/Onc, Department of Ob/Gyn/RS, and Ovarian Cancer Center of Excellence, University of Pittsburgh, Pittsburgh, PA, USA
15. Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA
16. Division of Epidemiology, Department of Health Science Research, Mayo Clinic College of Medicine, Rochester, MN, USA
17. Division of Biomedical Statistics and Informatics, Department of Health Science Research, Mayo Clinic, Rochester, MN, USA
18. Department of Community and Family Medicine, Duke University Medical Center, Durham, NC, USA
19. Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, NC, USA
20. Obstetrics and Gynecology Epidemiology Center, Brigham and Women’s Hospital, Boston, MA, USA
21. Robert Wood Johnson Medical School, The Cancer Institute of New Jersey, New Brunswick, NJ, USA
22. Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
23. UMDNJ-School of Public Health, Piscataway, NJ, USA
24. Department of Epidemiology, Biostatistics and HTA, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
25. Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
26. Comprehensive Cancer Center, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
27. Department of Gynecology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
28. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
29. Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
30. Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA
31. Department of Gynecological Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA
32. Strangeways Research Laboratory, Department of Oncology, University of Cambridge, Cambridge, UK
33. Department of Health Research and Policy, Epidemiology, Stanford University School of Medicine, Stanford, CA, USA
34. Epidemiology Center, College of Medicine, University of South Florida, Tampa, FL, USA
35. Womens Cancer, EGA Institute for Women’s Health, University College London, London, UK
36. Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA
37. Department of Epidemiology and Public Health, Yale University School of Public Health and School of Medicine, New Haven, CT, USA - ISSN：1573-7225
文摘
Purpose The majority of previous studies have observed an increased risk of mucinous ovarian tumors associated with cigarette smoking, but the association with other histological types is unclear. In a large pooled analysis, we examined the risk of epithelial ovarian cancer associated with multiple measures of cigarette smoking with a focus on characterizing risks according to tumor behavior and histology. Methods We used data from 21 case–control studies of ovarian cancer (19,066 controls, 11,972 invasive and 2,752 borderline cases). Study-specific odds ratios (OR) and 95?% confidence intervals (CI) were obtained from logistic regression models and combined into a pooled odds ratio using a random effects model. Results Current cigarette smoking increased the risk of invasive mucinous (OR?=?1.31; 95?% CI: 1.03-.65) and borderline mucinous ovarian tumors (OR?=?1.83; 95?% CI: 1.39-.41), while former smoking increased the risk of borderline serous ovarian tumors (OR?=?1.30; 95?% CI: 1.12-.50). For these histological types, consistent dose–response associations were observed. No convincing associations between smoking and risk of invasive serous and endometrioid ovarian cancer were observed, while our results provided some evidence of a decreased risk of invasive clear cell ovarian cancer. Conclusions Our results revealed marked differences in the risk profiles of histological types of ovarian cancer with regard to cigarette smoking, although the magnitude of the observed associations was modest. Our findings, which may reflect different etiologies of the histological types, add to the fact that ovarian cancer is a heterogeneous disease.